| Mon, Oct 5, 2009 | | • | AVI BioPharma Receives Expanded Contract From U.S. Department of Defense to Develop Its Drug Candidate for the Treatment of Junin Virus Infection
Marketwire (Mon, Oct 5)
| | Sat, Oct 3, 2009 | | • | This Week's Barron's Roundup
at TheStreet.com (Sat, Oct 3)
| | Tue, Sep 15, 2009 | | • | AVI BioPharma, Inc. Announces Presentations at Upcoming Investment Conferences
Marketwire (Tue, Sep 15)
| | Mon, Sep 14, 2009 | | • | AVI BioPharma, Inc. Demonstrates Effectiveness of Immune Control via RNA-Based Therapeutics in Hemorrhagic Virus Infections
Marketwire (Mon, Sep 14)
| | • | AVI BioPharma Presents Safety Data in Duchenne Muscular Dystrophy at 14th Annual International Congress of the World Muscle Society
Marketwire (Mon, Sep 14)
| | Thu, Sep 3, 2009 | | • | 5 Cold Stocks Heating Up
at Motley Fool (Thu, Sep 3)
| | Wed, Sep 2, 2009 | | • | AVI BioPharma, Inc. Presenting at Rodman & Renshaw Global Investment Conference
Marketwire (Wed, Sep 2)
| | Thu, Aug 27, 2009 | | • | AVI BioPharma, Inc. to Present Leading PPMO Drug Delivery Technology at Upcoming Scientific Meetings
Marketwire (Thu, Aug 27)
| | Wed, Aug 26, 2009 | | • | Iron Mountain Chair Sells $4.4M Worth
TheStreet.com (Wed, Aug 26)
| | Tue, Aug 25, 2009 | | • | AVI BioPharma Phase 1 Proof of Concept and Safety Data for AVI-4658 in Duchenne Muscular Dystrophy Featured in Lancet Neurology
Marketwire (Tue, Aug 25)
| | • | AVI BioPharma to Present Safety Data in Duchenne Muscular Dystrophy at 14th Annual International Congress of the World Muscle Society
Marketwire (Tue, Aug 25)
| | • | AVI BioPharma Announces Closing of Public Offering of Common Stock and Warrants
Marketwire (Tue, Aug 25)
| | Mon, Aug 24, 2009 | | • | AVI BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Mon, Aug 24)
| | Thu, Aug 20, 2009 | | • | AVI BioPharma Announces Pricing of Public Offering of Common Stock and Warrants
Marketwire (Thu, Aug 20)
| | Wed, Aug 19, 2009 | | • | AVI BioPharma, Inc. Announces Proposed Public Offering of Common Stock and Warrants
Marketwire (Wed, Aug 19)
| | Mon, Aug 10, 2009 | | • | AVI BioPharma Announces Second Quarter 2009 Financial Results & Corporate Highlights
Marketwire (Mon, Aug 10)
| | • | AVI BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
EDGAR Online (Mon, Aug 10)
| | Mon, Aug 3, 2009 | | • | AVI BioPharma Announces Second Quarter 2009 Financial Results Conference Call
Marketwire (Mon, Aug 3)
| | Fri, Jul 31, 2009 | | • | AVI BioPharma, Inc. Files Shelf Registration Statement
Marketwire (Fri, Jul 31)
| | • | AVI BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Fri, Jul 31)
| | Thu, Jul 30, 2009 | | • | AVI BioPharma Moving Corporate Headquarters to Greater Seattle Area
Marketwire (Thu, Jul 30)
| | Wed, Jul 29, 2009 | | • | AVI BioPharma, Inc. Presenting at BMO Focus on Healthcare Conference
Marketwire (Wed, Jul 29)
| | • | AVI BioPharma, Inc. to Present at IBC Drug Discovery & Development Conference: Oligonucleotide Therapeutics -- From Concept to Implementation
Marketwire (Wed, Jul 29)
| | Tue, Jul 28, 2009 | | • | AVI BioPharma and Action Duchenne Team Up to Support Advancement of PMO-Based Therapeutics for Treatment of Duchenne Muscular Dystrophy
Marketwire (Tue, Jul 28)
| | Tue, Jul 14, 2009 | | • | AVI BioPharma, Inc. Presents at American Society of Virology Annual Meeting
Marketwire (Tue, Jul 14)
|
Add AVII News to My Yahoo!:
 
| |
|
0.31% Nasdaq 0.00%
Headlines
